Exploring how CARD11 mutations improve immune responses against tumors
Investigating mechanisms of CARD11 mutants in enhanced anti-tumor immunity and T cell fitness (For Kathleen Cheng)
This study is looking at how certain changes in a gene called CARD11 can help T cells become better at fighting tough solid tumors, with the hope of creating new treatments that could improve cancer care for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11031965 on NIH RePORTER |
What this research studies
This research investigates how specific mutations in the CARD11 gene can enhance the ability of T cells to fight tumors, particularly in solid cancers that are currently difficult to treat. By examining T cell neoplasms, the study aims to uncover genetic mechanisms that improve T cell fitness and effectiveness. The approach involves using advanced cellular therapies that leverage these mutations to boost anti-tumor immunity. Patients may benefit from new treatment strategies that could lead to better outcomes in cancer therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with solid tumors who may benefit from enhanced T cell therapies.
Not a fit: Patients with hematological malignancies or those who do not have solid tumors may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with solid tumors, improving their chances of recovery.
How similar studies have performed: Other research has shown promising results using genetic modifications in T cells to improve cancer treatment, suggesting potential success for this approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Cheng, Kathleen — Northwestern University at Chicago
- Study coordinator: Cheng, Kathleen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.